1,2-dichloroethane increases expression ISO RGD:733701 6480464 ethylene dichloride results in increased expression of EPB41L1 mRNA CTD PMID:28960355 17beta-estradiol increases expression ISO RGD:733700 6480464 Estradiol results in increased expression of EPB41L1 mRNA CTD PMID:23019147 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:733700 6480464 2 more ... CTD PMID:31675489 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO RGD:733701 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733700 6480464 Tetrachlorodibenzodioxin affects the expression of EPB41L1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733701 6480464 [Tetrachlorodibenzodioxin affects the methylation of EPB41L1 intron] which results in decreased expression of EPB41L1 mRNA CTD PMID:33017471 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EPB41L1 mRNA CTD PMID:15644576 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733701 6480464 Tetrachlorodibenzodioxin results in decreased expression of EPB41L1 mRNA CTD PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733701 6480464 Tetrachlorodibenzodioxin affects the expression of EPB41L1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of EPB41L1 mRNA CTD PMID:21215274 2,4,6-tribromophenol decreases expression ISO RGD:733700 6480464 2 more ... CTD PMID:31675489 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:733700 6480464 tetrabromobisphenol A results in decreased expression of EPB41L1 protein CTD PMID:31675489 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of EPB41L1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:733700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of EPB41L1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects methylation ISO RGD:733701 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of EPB41L1 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases expression ISO RGD:733701 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of EPB41L1 mRNA CTD PMID:33297965 4-[1-hydroxy-2-[4-(phenylmethyl)-1-piperidinyl]propyl]phenol multiple interactions EXP 6480464 ifenprodil inhibits the reaction [Isoflurane results in decreased expression of EPB41L1 protein] CTD PMID:31672664 acrolein multiple interactions ISO RGD:733700 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of EPB41L1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of EPB41L1 mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of EPB41L1 mRNA CTD PMID:28959563 aflatoxin B1 increases methylation ISO RGD:733700 6480464 Aflatoxin B1 results in increased methylation of EPB41L1 exon, Aflatoxin B1 results in increased methylation of EPB41L1 gene CTD PMID:27153756 , PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:733700 6480464 aflatoxin B2 results in increased methylation of EPB41L1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:733700 6480464 Tretinoin results in increased expression of EPB41L1 mRNA, Tretinoin results in increased expression of EPB41L1 protein CTD PMID:23724009 , PMID:30093655 all-trans-retinoic acid decreases expression ISO RGD:733700 6480464 Tretinoin results in decreased expression of EPB41L1 mRNA CTD PMID:33167477 all-trans-retinoic acid increases expression ISO RGD:733701 6480464 Tretinoin results in increased expression of EPB41L1 mRNA CTD PMID:16169686 alpha-pinene multiple interactions ISO RGD:733700 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of EPB41L1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of EPB41L1 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of EPB41L1 mRNA CTD PMID:16483693 arsenite(3-) increases methylation ISO RGD:733700 6480464 arsenite results in increased methylation of EPB41L1 promoter CTD PMID:23974009 arsenous acid decreases response to substance ISO RGD:733700 6480464 EPB41L1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 arsenous acid increases expression ISO RGD:733700 6480464 Arsenic Trioxide results in increased expression of EPB41L1 protein CTD PMID:30093655 benzene decreases expression EXP 6480464 Benzene results in decreased expression of EPB41L1 mRNA CTD PMID:17905399 benzo[a]pyrene decreases expression ISO RGD:733700 6480464 Benzo(a)pyrene results in decreased expression of EPB41L1 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO RGD:733700 6480464 Benzo(a)pyrene affects the methylation of EPB41L1 3' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:733700 6480464 Benzo(a)pyrene results in increased methylation of EPB41L1 5' UTR, Benzo(a)pyrene results in increased methylation of EPB41L1 exon CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:733701 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of EPB41L1 mRNA] CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:733700 6480464 Benzo(a)pyrene results in increased expression of EPB41L1 mRNA, Benzo(a)pyrene results in increased expression of EPB41L1 protein CTD PMID:20106945 more ... benzo[e]pyrene increases methylation ISO RGD:733700 6480464 benzo(e)pyrene results in increased methylation of EPB41L1 intron CTD PMID:30157460 bis(2-chloroethyl) sulfide increases phosphorylation ISO RGD:733700 6480464 Mustard Gas results in increased phosphorylation of EPB41L1 protein CTD PMID:19845377 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of EPB41L1 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:733700 6480464 bisphenol A results in decreased methylation of EPB41L1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:733700 6480464 bisphenol A results in increased expression of EPB41L1 protein CTD PMID:33376534 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EPB41L1 mRNA CTD PMID:30816183 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of EPB41L1 mRNA CTD PMID:31129395 Bisphenol B increases expression ISO RGD:733700 6480464 bisphenol B results in increased expression of EPB41L1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:733700 6480464 bisphenol F results in increased expression of EPB41L1 protein CTD PMID:34186270 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of EPB41L1 protein CTD PMID:28903499 cadmium atom increases expression ISO RGD:733700 6480464 Cadmium results in increased expression of EPB41L1 mRNA CTD PMID:24376830 caffeine affects phosphorylation ISO RGD:733700 6480464 Caffeine affects the phosphorylation of EPB41L1 protein CTD PMID:35688186 choline multiple interactions ISO RGD:733701 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPB41L1 mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:733700 6480464 Cisplatin results in increased expression of EPB41L1 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:733700 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of EPB41L1 mRNA CTD PMID:27392435 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of EPB41L1 mRNA CTD PMID:17602206 copper(II) sulfate increases expression ISO RGD:733700 6480464 Copper Sulfate results in increased expression of EPB41L1 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:733700 6480464 coumarin results in increased phosphorylation of EPB41L1 protein CTD PMID:35688186 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of EPB41L1 mRNA CTD PMID:26577399 dexamethasone multiple interactions ISO RGD:733700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of EPB41L1 mRNA CTD PMID:28628672 diarsenic trioxide decreases response to substance ISO RGD:733700 6480464 EPB41L1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide increases expression ISO RGD:733700 6480464 Arsenic Trioxide results in increased expression of EPB41L1 protein CTD PMID:30093655 dicrotophos increases expression ISO RGD:733700 6480464 dicrotophos results in increased expression of EPB41L1 mRNA CTD PMID:28302478 dimethylselenide multiple interactions ISO RGD:733700 6480464 [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of EPB41L1 mRNA CTD PMID:33656867 dorsomorphin multiple interactions ISO RGD:733700 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPB41L1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733700 6480464 Doxorubicin results in decreased expression of EPB41L1 mRNA CTD PMID:29803840 ethanol increases expression ISO RGD:733701 6480464 Ethanol results in increased expression of EPB41L1 mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:733701 6480464 Ethanol affects the expression of EPB41L1 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:733701 6480464 Ethanol affects the splicing of EPB41L1 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:733701 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPB41L1 mRNA CTD PMID:20938992 fonofos increases methylation ISO RGD:733700 6480464 Fonofos results in increased methylation of EPB41L1 promoter CTD PMID:22847954 genistein increases expression ISO RGD:733700 6480464 Genistein results in increased expression of EPB41L1 mRNA CTD PMID:23019147 hydrogen peroxide affects expression ISO RGD:733700 6480464 Hydrogen Peroxide affects the expression of EPB41L1 mRNA CTD PMID:20044591 indometacin multiple interactions ISO RGD:733700 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of EPB41L1 mRNA CTD PMID:28628672 isoflurane decreases expression EXP 6480464 Isoflurane results in decreased expression of EPB41L1 protein CTD PMID:31672664 isoflurane multiple interactions EXP 6480464 CAPN2 protein affects the reaction [Isoflurane results in decreased expression of EPB41L1 protein], ifenprodil inhibits the reaction [Isoflurane results in decreased expression of EPB41L1 protein] CTD PMID:31672664 ivermectin decreases expression ISO RGD:733700 6480464 Ivermectin results in decreased expression of EPB41L1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:733701 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPB41L1 mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:733700 6480464 Lead affects the expression of EPB41L1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:733700 6480464 Lead affects the expression of EPB41L1 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:733700 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of EPB41L1 mRNA CTD PMID:35811015 methamphetamine decreases methylation ISO RGD:733701 6480464 Methamphetamine results in decreased methylation of EPB41L1 promoter CTD PMID:26307267 methapyrilene increases methylation ISO RGD:733700 6480464 Methapyrilene results in increased methylation of EPB41L1 intron CTD PMID:30157460 methylphenidate decreases expression ISO RGD:733701 6480464 Methylphenidate results in decreased expression of EPB41L1 mRNA CTD PMID:22470460 mono(2-ethylhexyl) phthalate affects expression ISO RGD:733701 6480464 mono-(2-ethylhexyl)phthalate affects the expression of EPB41L1 mRNA CTD PMID:21195148 Monobutylphthalate affects expression ISO RGD:733701 6480464 monobutyl phthalate affects the expression of EPB41L1 mRNA CTD PMID:21195148 ozone multiple interactions ISO RGD:733700 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of EPB41L1 mRNA more ... CTD PMID:32699268 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of EPB41L1 mRNA CTD PMID:27638505 parathion increases methylation ISO RGD:733700 6480464 Parathion results in increased methylation of EPB41L1 promoter CTD PMID:22847954 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 perfluorononanoic acid increases expression ISO RGD:733700 6480464 perfluoro-n-nonanoic acid results in increased expression of EPB41L1 mRNA CTD PMID:32588087 phenylmercury acetate decreases expression ISO RGD:733700 6480464 Phenylmercuric Acetate results in decreased expression of EPB41L1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733700 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPB41L1 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:733701 6480464 pirinixic acid results in increased expression of EPB41L1 mRNA CTD PMID:23811191 quercetin increases expression ISO RGD:733700 6480464 Quercetin results in increased expression of EPB41L1 mRNA CTD PMID:21632981 reactive oxygen species multiple interactions ISO RGD:733700 6480464 [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of EPB41L1 mRNA CTD PMID:33656867 resveratrol multiple interactions ISO RGD:733700 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of EPB41L1 mRNA CTD PMID:23557933 rotenone affects expression EXP 6480464 Rotenone affects the expression of EPB41L1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:733700 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of EPB41L1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:733700 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPB41L1 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:733700 6480464 Silicon Dioxide results in decreased expression of EPB41L1 mRNA CTD PMID:25351596 sodium arsenate increases expression ISO RGD:733701 6480464 sodium arsenate results in increased expression of EPB41L1 mRNA CTD PMID:30953684 sulforaphane decreases expression ISO RGD:733700 6480464 sulforaphane results in decreased expression of EPB41L1 mRNA CTD PMID:31838189 terbufos increases methylation ISO RGD:733700 6480464 terbufos results in increased methylation of EPB41L1 promoter CTD PMID:22847954 testosterone increases expression ISO RGD:733701 6480464 Testosterone deficiency results in increased expression of EPB41L1 mRNA CTD PMID:33848595 tetrachloromethane decreases expression ISO RGD:733701 6480464 Carbon Tetrachloride results in decreased expression of EPB41L1 mRNA CTD PMID:17484886 thimerosal decreases expression ISO RGD:733700 6480464 Thimerosal results in decreased expression of EPB41L1 mRNA CTD PMID:27188386 titanium dioxide increases expression ISO RGD:733701 6480464 titanium dioxide results in increased expression of EPB41L1 mRNA CTD PMID:29264374 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of EPB41L1 mRNA CTD PMID:31129395 trichostatin A decreases expression ISO RGD:733700 6480464 trichostatin A results in decreased expression of EPB41L1 mRNA CTD PMID:24935251 trimellitic anhydride decreases expression ISO RGD:733701 6480464 trimellitic anhydride results in decreased expression of EPB41L1 mRNA CTD PMID:19042947 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of EPB41L1 mRNA CTD PMID:30589522 triptonide decreases expression ISO RGD:733701 6480464 triptonide results in decreased expression of EPB41L1 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:733700 6480464 tris(2-butoxyethyl) phosphate affects the expression of EPB41L1 mRNA CTD PMID:29024780 valproic acid increases expression ISO RGD:733700 6480464 Valproic Acid results in increased expression of EPB41L1 mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:733700 6480464 Valproic Acid affects the expression of EPB41L1 mRNA CTD PMID:25979313 valproic acid affects expression ISO RGD:733701 6480464 Valproic Acid affects the expression of EPB41L1 mRNA CTD PMID:17963808 vorinostat decreases expression ISO RGD:733700 6480464 vorinostat results in decreased expression of EPB41L1 mRNA CTD PMID:27188386
